Oklahoma · 2026

HB 1416

Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.

Bill record: Open States bulk CSV (bills/votes) ocd-bill/33f16677-4ac1-46ac-8d4a-c564de6ec547 CC0-1.0

Issue tags AI-classified

Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)

Sponsors

Roll-call votes on this bill

Motion / questionChamberStageRollOutcomeYeaNayOtherDateSource
Third Reading lower 1df44226-a7f5-4f28-8b6a-ab963febb385 pass 86 7 2 Mar 3, 2025 Open States bulk CSV (bills/votes) ocd-vote/1df44226-a7f5-4f28-8b6a-ab963febb385 CC0-1.0
Health And Human Services Oversight Committee: Do Pass As Amended By Cs lower 13fbcdba-7b69-42ae-89f9-a01a34f9d915 pass 9 0 0 Feb 26, 2025 Open States bulk CSV (bills/votes) ocd-vote/13fbcdba-7b69-42ae-89f9-a01a34f9d915 CC0-1.0
Public Health Committee: Do Pass lower f44ea95e-d84c-4afe-aea3-6cca0257542e pass 6 0 0 Feb 5, 2025 Open States bulk CSV (bills/votes) ocd-vote/f44ea95e-d84c-4afe-aea3-6cca0257542e CC0-1.0